Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Exact Sciences Cor
(NQ:
EXAS
)
49.84
-4.24 (-7.84%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 24, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Exact Sciences Cor
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Exact Sciences Guidance Beat Street View, Analyst Says Company Fires All Cylinders
May 10, 2023
Exact Sciences Corp's (NASDAQ: EXAS) Q1 revenues increased 24% Y/Y to $602 million, beating the average Wall Street esti
Via
Benzinga
Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday
May 10, 2023
U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023
May 10, 2023
Via
Benzinga
Exact Sciences (EXAS) Q1 2023 Earnings Call Transcript
May 09, 2023
EXAS earnings call for the period ending March 31, 2023.
Via
The Motley Fool
Analyst Ratings for Exact Sciences
March 03, 2023
Via
Benzinga
EXAS Stock Earnings: Exact Sciences Beats EPS, Revenue Estimates
May 09, 2023
EXAS stock posted Q1 results that include a loss per share of 42 cents and revenue that was much better than analysts expected.
Via
InvestorPlace
Exact Sciences Posts Its 11th Consecutive Sales Beat As It Targets 'The Most Preventable' Cancer
May 09, 2023
The company sells Cologuard, a test to screen for colon cancer.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023
May 05, 2023
Via
Benzinga
Canaccord Genuity Maintains Buy Rating for Exact Sciences: Here's What You Need To Know
February 22, 2023
Via
Benzinga
3 Stocks That AI Predicts Will Outperform the Market
May 04, 2023
Here are three stocks that came up when I asked the generative AI chatbot that powers Bing chat to make some AI stock recommendations
Via
InvestorPlace
The 7 Best Biotech Stocks for Personalized Medicine Investors
April 25, 2023
Personalized Medicine Stocks Promise to Make Healthcare More Individualized with therapeutics based on individual genetics.
Via
InvestorPlace
Cathie Wood’s Next Big Bet: 3 Disruptive Innovations to Watch
April 24, 2023
These Cathie Wood stocks could deliver massive gains in the coming years as they disrupt traditional industries.
Via
InvestorPlace
What Has Cathie Wood Been Trading?
April 19, 2023
The story of Ark Invest, Wall Street veteran Cathie Wood’s lineup of actively managed, innovation-centric ETFs is well-known at this point. Ark has been defined by big bets, big wins, big losses, and...
Via
Benzinga
2 Supercharged Growth Stocks That Could Rocket 116% to 899% Higher, According to Wall Street
April 15, 2023
Find out why expectations are so high for these two innovative businesses.
Via
The Motley Fool
The 3 Best Millionaire-Maker Stocks to Buy for April 2023
April 07, 2023
These millionaire-maker stocks certainly have the growth profiles to help investors reach their goals of becoming a millionaire.
Via
InvestorPlace
3 Cathie Wood Stocks for Your April Must-Buy List
April 04, 2023
Cathie Wood stocks are doing much better in 2023 than last year. Here are three to put on your April must-buy list.
Via
InvestorPlace
FTC Orders Biotech Illumina To Unwind Grail Deal Amid Icahn Battle
April 03, 2023
The FTC ordered Monday that biotech firm Illumina must unwind its $8 billion purchase of the cancer-testing startup Grail. ILMN stock fell.
Via
Investor's Business Daily
3 Stocks With Superior Potential for Super-Sized Gains in 2023
March 22, 2023
Investing in stocks with potential is a great way to make money as long as you do your research and understand the risks involved.
Via
InvestorPlace
If You Invested $10,000 in Exact Sciences in 2018, This Is How Much You Would Have Today
March 16, 2023
Has this been a market-beating investment?
Via
The Motley Fool
EXAS Stock Is a Hidden Gem in the Healthcare Sector for Bold Investors
March 16, 2023
Patient investors who have room for an intriguing medical-niche investment in their portfolio should take a closer look at EXAS stock.
Via
InvestorPlace
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector
March 15, 2023
To play a permanently relevant industry with the broadest canvas possible, consider acquiring the best biotech ETFs to buy.
Via
InvestorPlace
Meta Platforms To Rally Over 36%? Here Are 10 Other Analyst Forecasts For Wednesday
March 15, 2023
Credit Suisse cut the price target for Zscaler, Inc. (NASDAQ: ZS) from $275 to $165. Credit Suisse analyst Sami Badri maintained an Outperform rating. Zscaler shares fell 1.9% to $105.95 in pre-market...
Via
Benzinga
7 Growth Stocks Sitting in a Sweet Spot
March 14, 2023
Offering ample growth potential, and each attractively-priced, now's the time to buy these seven growth stocks.
Via
InvestorPlace
A Nasdaq Bull Market Is Coming: 2 Revolutionary Stocks to Buy and Hold
March 12, 2023
It pays to be an innovator.
Via
The Motley Fool
What You Missed On Wall Street On Thursday
March 09, 2023
SVB Financial is lower after the company announced it was undertaking a strategic repositioning of its balance sheet and also provided a negative update to both Q1 and full-year 2023 guidance.
Via
Talk Markets
Benzinga's Top Ratings Upgrades, Downgrades For March 9, 2023
March 09, 2023
Via
Benzinga
Cathie Wood Is Betting Big on These 5 AI Stocks
March 01, 2023
Investors are betting on Cathie Wood again thanks to growing AI stocks interest. Wood's Ark Invest holds several compelling AI picks.
Via
InvestorPlace
Exact Sciences (EXAS) Q4 2022 Earnings Call Transcript
February 21, 2023
EXAS earnings call for the period ending December 31, 2022.
Via
The Motley Fool
After-Hours Action: What's Going On With Exact Sciences Stock?
February 21, 2023
Exact Sciences Corp (NASDAQ: EXAS) shares are facing selling pressure after the close on Tuesday on the heels of the company's quarterly results.
Via
Benzinga
Exact Sciences, Which Outperforms 95% Of All Stocks, Just Beat Quarterly Estimates
February 21, 2023
Exact Sciences is leaned on Cologuard for strong fourth-quarter sales growth.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
8
9
...
12
13
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.